| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aldeyra Therapeutics, Inc. (ALDX) has 2 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. ALDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 221.8K | $434.7K | - | |
| Other | 7.5K | $14.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2019 | Brady Todd C | President And CEO | Buy | 8,710 | $5.68 | $49,483.25 | +1.4% | |
| Sep 23, 2019 | Brady Todd C | President And CEO | Buy | 8,680 | $5.81 | $50,432.54 | +1.4% | |
| Sep 18, 2019 | Brady Todd C | President And CEO | Buy | 14,288 | $5.91 | $84,464.94 | +2.4% | |
| Sep 17, 2019 | Bronstein Ben | Director | Buy | 1,700 | $5.85 | $9,945.00 | +10.0% | |
| Sep 16, 2019 | Brady Todd C | President And CEO | Buy | 13,000 | $5.85 | $75,990.00 | +1.1% | |
| Sep 13, 2019 | Douglas Richard | Director | Buy | 5,000 | $6.00 | $30,000.00 | +6.3% | |
| Sep 12, 2019 | Joyce Martin Joseph | Director | Buy | 1,700 | $5.86 | $9,964.21 | +9.5% | |
| Sep 12, 2019 | Douglas Richard | Director | Buy | 20,000 | $5.89 | $117,805.00 | +15.4% | |
| Sep 10, 2019 | Brady Todd C | President And CEO | Buy | 20,000 | $5.14 | $102,824.00 | +1.8% | |
| Sep 10, 2019 | Douglas Richard | Director | Buy | 20,000 | $5.00 | $99,963.00 | +22.2% |